Targeted Therapeutics for Transthyretin Cardiac Amyloidosis: Proof That Precision Medicine in Heart Failure Is a Possibility?

Sanjiv J. Shah*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)444-447
Number of pages4
JournalCirculation
Volume139
Issue number4
DOIs
StatePublished - Jan 22 2019

Keywords

  • Editorials
  • amyloidosis
  • heart failure
  • precision medicine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this